BATON ROUGE – A lawsuit pitting Louisiana towards main producers of insulin is headed to federal courtroom.
The case — filed in March on the state stage by Legal professional Normal Jeff Landry — will now be heard in US District Court docket in Baton Rouge.
It focuses on what the plaintiff describes as a concerted and coordinated effort to hike the worth of insulin, which is important for diabetics working to handle their situation.
Greater than half 1,000,000 Louisiana residents are believed to have diabetes.
The state is considered one of a rising quantity to file go well with towards pharmaceutical companies and drug distributors, alleging that they’re working in live performance to overcharge for insulin.
Within the lawsuit, the State claims that “the costs paid by the residents of Louisiana for sure insulin merchandise are artificially inflated by a sprawling ‘Insulin Pricing Scheme’ between sure Pharmacy Profit Managers and sure insulin producers.”
It seeks to cap and scale back the price of insulin.
The checklist of defendants contains Sanofi LLC, Caremark Well being and CVS Well being Corp., together with others.